Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma

Small- and medium-sized choroidal melanomas can be adequately treated with 106Ru brachytherapy, with high rates of tumor control and ocular preservation. Moreover, acceptable incidence of complications such as glaucoma and cataract are seen, and a reasonable part of patients stay with a minimum functional VA.